Dynamic Cross Talk between S1P and CXCL12 Regulates Hematopoietic Stem Cells Migration, Development and Bone Remodeling

被引:32
作者
Golan, Karin [1 ]
Kollet, Orit [1 ]
Lapidot, Tsvee [1 ]
机构
[1] Weizmann Inst Sci, Dept Immunol, 234 Herzl Str, IL-76100 Rehovot, Israel
来源
PHARMACEUTICALS | 2013年 / 6卷 / 09期
关键词
hematopoietic stem cells; CXCL12/CXCR4; S1P; mobilization; bone remodeling;
D O I
10.3390/ph6091145
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Hematopoietic stem cells (HSCs) are mostly retained in a quiescent non-motile mode in their bone marrow (BM) niches, shifting to a migratory cycling and differentiating state to replenish the blood with mature leukocytes on demand. The balance between the major chemo-attractants CXCL12, predominantly in the BM, and S1P, mainly in the blood, dynamically regulates HSC recruitment to the circulation versus their retention in the BM. During alarm situations, stress-signals induce a decrease in CXCL12 levels in the BM, while S1P levels are rapidly and transiently increased in the circulation, thus favoring mobilization of stem cells as part of host defense and repair mechanisms. Myeloid cytokines, including G-CSF, up-regulate S1P signaling in the BM via the PI3K pathway. Induced CXCL12 secretion from stromal cells via reactive oxygen species (ROS) generation and increased S1P1 expression and ROS signaling in HSCs, all facilitate mobilization. Bone turnover is also modulated by both CXCL12 and S1P, regulating the dynamic BM stromal microenvironment, osteoclasts and stem cell niches which all functionally express CXCL12 and S1P receptors. Overall, CXCL12 and S1P levels in the BM and circulation are synchronized to mutually control HSC motility, leukocyte production and osteoclast/osteoblast bone turnover during homeostasis and stress situations.
引用
收藏
页码:1145 / 1169
页数:25
相关论文
共 146 条
[1]   The Wnt antagonist Dickkopf-1 mobilizes vasculogenic progenitor cells via activation of the bone marrow endosteal stem cell niche [J].
Aicher, Alexandra ;
Kollet, Orit ;
Heeschen, Christopher ;
Liebner, Stefan ;
Urbich, Carmen ;
Ihling, Christian ;
Orlandi, Alessia ;
Lapidot, Tsvee ;
Zeiher, Andreas M. ;
Dimmeler, Stefanie .
CIRCULATION RESEARCH, 2008, 103 (08) :796-803
[2]   Autocrine and paracrine roles of sphingosine-1-phosphate [J].
Alvarez, Sergio E. ;
Milstien, Sheldon ;
Spiegel, Sarah .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2007, 18 (08) :300-307
[3]   Molecular Intercommunication between the Complement and Coagulation Systems [J].
Amara, Umme ;
Flierl, Michael A. ;
Rittirsch, Daniel ;
Klos, Andreas ;
Chen, Hui ;
Acker, Barbara ;
Brueckner, Uwe B. ;
Nilsson, Bo ;
Gebhard, Florian ;
Lambris, John D. ;
Huber-Lang, Markus .
JOURNAL OF IMMUNOLOGY, 2010, 185 (09) :5628-5636
[4]   Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny [J].
Ara, T ;
Tokoyoda, K ;
Sugiyama, T ;
Egawa, T ;
Kawabata, K ;
Nagasawa, T .
IMMUNITY, 2003, 19 (02) :257-267
[5]   CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow [J].
Avigdor, A ;
Goichberg, P ;
Shivtiel, S ;
Dar, A ;
Peled, A ;
Samira, S ;
Kollet, O ;
Hershkoviz, R ;
Alon, R ;
Hardan, I ;
Ben-Hur, H ;
Naor, D ;
Nagler, A ;
Lapidot, T .
BLOOD, 2004, 103 (08) :2981-2989
[6]   Role of sphingosine 1-phosphate in trafficking and mobilization of hematopoietic stem cells [J].
Bendall, Linda J. ;
Basnett, Jordan .
CURRENT OPINION IN HEMATOLOGY, 2013, 20 (04) :281-288
[7]   Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts [J].
Boyce, Brendan F. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (04) :711-722
[8]   FTY720: Sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function [J].
Brinkmann, V ;
Cyster, JG ;
Hla, T .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (07) :1019-1025
[9]   Chemokines in hematopoiesis [J].
Broxmeyer, Hal E. .
CURRENT OPINION IN HEMATOLOGY, 2008, 15 (01) :49-58
[10]   Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist [J].
Broxmeyer, HE ;
Orschell, CM ;
Clapp, DW ;
Hangoc, G ;
Cooper, S ;
Plett, PA ;
Liles, WC ;
Li, XX ;
Graham-Evans, B ;
Campbell, TB ;
Calandra, G ;
Bridger, G ;
Dale, DC ;
Srour, EF .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (08) :1307-1318